Bioorganic and Medicinal Chemistry Letters p. 3193 - 3198 (1998)
Update date:2022-07-30
Topics:
St-Denis, Yves
Augelli-Szafran, Corinne E.
Bachand, Benoit
Berryman, Kent A.
DiMaio, John
Doherty, Annette M.
Edmunds, Jeremy J.
Leblond, Lorraine
Levesque, Sophie
Narasimhan, Lakshmi S.
Penvose-Yi, Jan R.
Rubin, J. Ronald
Tarazi, Micheline
Winocour, Peter D.
Siddiqui, M. Arshad
Peptidomimetic inhibitors of general structure 1 have been prepared. Optimization of the binding affinities of these compounds through variation of the P3 hydrophobic residue is described. Selected substituted bicylic lactams displayed interesting pharmacological profiles both in vitro and in vivo.
View MoreContact:+86-371-67759225
Address:No.32, Jinsuo Road, High-tech Zone
BrightGene Bio-Medical Technology Co., Ltd.
website:https://en.bright-gene.com/
Contact:+86-512-62551801
Address:Building C25 - C31, No. 218 Xinghu Road, Suzhou Industrial Park, Suzhou, Jiangsu, China.
Contact:+44 7958 511245
Address:PO Box 469, Manchester, UK
Suzhou Time-chem Technologies Co., Ltd.
Contact:0512-63983931/68086856
Address:No. 1326 of Binhe Road, New District, Suzhou, Jiangsu, P. R. China
Nanjing Raise Pharmatech Co., Ltd
website:http://www.raisechem.com
Contact:+86-25-58649566
Address:B381,No.606,Ningliu Road,Jiangbei New Area,Nanjing,Jiangsu Province,China
Doi:10.1021/acs.jafc.0c03113
(2020)Doi:10.1021/acs.orglett.5b02413
(2015)Doi:10.1021/jo01149a028
(1950)Doi:10.1021/ja9832818
(1999)Doi:10.1016/S0040-4039(99)00169-0
(1999)Doi:10.1016/j.poly.2010.02.022
(2010)
